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Conventional stroke risk factors often explain stroke
incompletely, particularly in young subjects.1 Systemic infection
and inflammation have been considered to modify stroke risk
independently of conventional risk factors.2 Traditional risk
factors, genetic predisposition and chronic and acute infection
and inflammation appear to be linked tightly to each other and
to influence the likelihood of thrombotic events.2 It is feasible
that inflammation and systemic infection result in activation of
the thrombotic system, adding to conventional risk factors and
resulting in ischaemic stroke.2
It is possible to assess systemic inflammation and infection
indirectly in a number of ways, including using the C-reactive
protein (CRP) level, erythrocyte sedimentation rate (ESR), and
white cell count (WCC).3 Elevated levels of CRP, an acute-phase
reactant that acts as a marker for systemic inflammation, have
been described among patients with acute myocardial
ischaemia4,5 and cerebrovascular disease.6,7 An elevated ESR is
also known to be a nonspecific but reliable marker of infection
and inflammation.8,9 The CRP is not readily available within the
public sector outside major centres in South Africa, while the
ESR is easy to perform, inexpensive and readily available even
in the most remote areas of the country. It is useful not only as
a potential diagnostic tool, but also as a research tool for
assessing underlying systemic inflammation, which may
predispose to risk of future cerebrovascular events.
D-dimers are a marker of activation of the coagulation and
fibrinolytic systems in hypercoagulable states10 and thrombotic
disorders.11-14 They have been shown to be elevated, particularly
in those patients who later develop vascular events.15-17
The aim of this study was to determine whether ischaemic
stroke patients with raised D-dimers, indicating continuing
thrombosis and fibrinolysis, are more likely to have evidence of
concurrent infection and/or inflammation as manifested by a
raised WCC and ESR, than ischaemic stroke patients without
raised D-dimers. We attempted to correlate a prothrombotic
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Objective. Systemic infection and inflammation have been
implicated in the aetiology of thrombotic cerebral events,
particularly in younger patients. We decided to determine
whether those patients with raised D-dimer levels, indicating
continuing thrombosis and fibrinolysis, had evidence of
concurrent infection or inflammation as manifested by a raised
erythrocyte sedimentation rate (ESR) measured after an
ischaemic stroke/transient ischaemic attack (TIA).
Methods. One hundred and forty-eight patients who had
suffered either single or recurrent cerebrovascular episodes
were analysed. The patients were referred to the thrombosis
and haemostasis unit at Johannesburg Hospital for evaluation
of their thrombotic profiles, including D-dimer levels.
Concurrent infection was assessed by measurement of white
cell count (WCC) and ESR. The variable time interval between
the date of the most recent cerebrovascular event and the date
of venesection was determined. A history was taken, a physical
and neurological examination was performed, and a cardiology
assessment and neuroimaging studies were done.
Results. Raised D-dimer levels correlated significantly with ESR
levels (p = 0.0094) in all patients. This was particularly evident
when comparing the 70 younger patients (aged less than 
45 years) with the 78 older patients (> 45 years) with raised 
D-dimers (p = 0.0070). When analysing other markers of
inflammation/infection in association with raised D-dimer
levels and ESR, mean fibrinogen levels were significantly
raised at 6.56 g/l (p = 0.0122). An elevated WCC, as a
categorical variable, was significantly associated with an
elevated ESR (p = 0.0092).
Conclusion. There is a significant correlation between elevated
D-dimer levels (indicating abnormalities of coagulation and
fibrinolysis) and markers of inflammatory and/or infective
processes. This is particularly evident in black patients below
the age of 45 years. These patients are believed to be at
decreased risk for generalised atheromatous disease compared
with older white patients. The ramifications of these findings
are potentially important with regard to thrombotic
cerebrovascular disease aetiology, investigation, management
and prevention.
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state with a background inflammatory process as a potential
risk factor for atherothrombotic cerebrovascular disease.
Subjects and methods
We included all patients with ischaemic stroke referred to the
haemostasis and thrombosis unit of the neurovascular clinic at
Johannesburg Hospital for analysis of their thrombotic profiles
between 1 January 1995 and 31 August 1997. All  patients had
suffered either single or multiple strokes and/or transient
ischaemic attacks (TIAs). 
A neurologist took a comprehensive history from each
patient or relative. Risk factors for vascular disease were
recorded, namely ischaemic heart disease, peripheral vascular
disease, diabetes mellitus, hypertension, migraine, gout,
smoking, alcohol consumption, hyperlipidaemia, valvular
heart disease, arrhythmias, previous cardiac or vascular
surgery, previous venous thrombo-embolic disease, family
history of atherosclerotic vascular disease, hyperthyroidism
and illicit drug abuse. Neurologists also took a current drug
history from all patients and noted the use of all anticoagulant
and antiplatelet agents. In addition, we assessed the presence
and frequency of other known risk factors associated with
elevation of plasma D-dimers including increasing age and
concurrent infection.
A full neurological and physical examination and review of
brain imaging was performed to determine the nature, territory
and number of cerebrovascular events. Cardiological evalua-
tion included an electrocardiograph and echocardiography as
appropriate.  Carotid artery Doppler evaluation was performed
routinely.
We evaluated patients for concurrent infection or
inflammation clinically and by measurement of their WCC and
Westergren ESR. A normal WCC was considered to be between
4 and 11 x 109/l. 
We performed a full thrombotic profile on each patient
including international normalised ratio (INR), partial
thromboplastin time (PTT), D-dimer levels, protein C assay,
protein S assay, antithrombin assay, activated protein C
resistance (APCR), polymerase chain reaction for factor V
Leiden mutation, lupus anticoagulant (LAC), fibrinogen levels
and thrombin time. 
We assessed the level of D-dimers in each patient using the
BIOPOOL Minutex D-dimer latex kit. Using this method,
normal D-dimer levels are below 250 ng/ml.12 For the purpose
of this study we considered elevated D-dimers to be above this
level.
Other laboratory parameters assessed were haemoglobin,
platelet count, random glucose, total cholesterol,
anticardiolipin antibodies (ACLA), antinuclear factor (ANF),
syphilis serology (RPR and TPHA) and free T4. In selected
patients in whom there was a clinical suspicion, we tested for
human immunodeficiency virus (HIV). 
Statistical analysis
We performed statistical analysis using the SAS computer
software package. The statistical tests used in order to
determine statistical significance were the Kruskal-Wallis test
and the Mann-Whitney U-test or Student’s t-test (depending on
the distribution of the dependent variable) for a continuous
dependent variable. We used the Fisher’s exact test and chi-
square for categorical dependent variables. In view of the fact
that many of the parameters assessed are non-parametric in
distribution, we computed mean values and analysed
significant differences using Wilcoxon’s rank-sum test. We
performed correlation analysis when seeking correlation
between continuous variables.
We compared patients who had suffered single or multiple
cerebrovascular events in terms of normal or elevated D-dimer
levels. In each group we determined whether the time interval
between the most recent event and the time of assessment was
more or less than 2 and 6 months.
We grouped D-dimer levels as normal or elevated. We then
compared ESR levels in individuals with elevated and normal
D-dimer levels.
We undertook comparisons between patients younger than
45 years and those 45 years and older, and between gender and
racial groups. We assessed fibrinogen levels and WCCs in
relation to D-dimer and ESR levels.
Ethics
We obtained ethics approval from the University of the
Witwatersrand Medical School Human Research Ethics
Committee, clearance number M980130. Obtaining informed
consent from patients included in the study was not deemed
necessary because all investigations were performed as part of
the routine clinical workup for patients suffering stroke-like
episodes.
Results
We assessed 148 patients (mean age of 47 years, range 15 - 79
years).  Ninety-three patients (63%) demonstrated normal D-
dimer levels at the time of testing, whereas 55 patients (37%)
had elevated D-dimers. Table I compares the age, gender, racial
group, proportion of young stroke patients, and nature of
stroke in those people with elevated and normal D-dimer
levels. The patients with elevated D-dimers were significantly
older than those with normal levels. Seventy per cent of the 70
young patients, i.e. 45 years of age or younger at the time of
their stroke or TIA, had normal D-dimer levels. There was no
statistically significant difference in the proportion of younger
and older patients with normal D-dimer levels. Fifty-seven per
cent of older patients had normal D-dimer levels (p = 0.092). 
When comparing the normal and elevated D-dimer groups
no significant difference was found in the number of strokes or
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TIAs or the proportion of patients presenting with a TIA rather
than a stroke. There was also no significant difference in the
proportion of blacks, whites and coloureds in the two groups.
Not one of the 9 Asian patients had elevated D-dimers. 
Although there was a wide range in the time from stroke or
TIA to measurement of D-dimers in both groups, overall the
mean time to assessment was shorter in the group with
elevated D-dimers (p = 0.0466). In 47 patients, D-dimer levels
were assessed within 2 months of their most recent
cerebrovascular event. Of these 47, 53% had elevated D-dimers.
A significantly smaller proportion (30%) of 101 patients
assessed at least 2 months after their event had elevated D-
dimer levels (p = 0.010).
The mean ESR was 8 mm/hour (range 0 - 45 mm/hour) in
the 93 patients with normal D-dimer levels. This was
significantly lower than the mean ESR of 16 mm/hour (range 
1 - 100 mm/hour) found in the patients with elevated D-dimer
levels (p = 0.0094) (Fig. 1). 
There was no significant difference between the ESR in
younger and older patients with normal D-dimers (p = 0.7588).
In the group with elevated D-dimers, however, the ESR was
higher in younger than in older patients (Fig. 2a and b). The
ESR was higher in the presence of raised D-dimers irrespective
of gender (Fig. 3a and b). We found a significant difference
between ESR levels in the 48 black and 82 white patients (p =
0.007). In the presence of elevated D-dimers, black patients had
higher ESRs than white patients (p = 0.008) (Fig. 4a and b). 
We correlated the level of fibrinogen, an acute-phase reactant
that increases in some inflammatory and hypercoagulable
states, with the ESR. In patients with normal D-dimers there
was no correlation with fibrinogen levels (Pearson’s correlation
coefficient 0.05). However, in patients with elevated D-dimers
Table I. Characteristics of stroke patients with normal and elevated* D-dimer levels
Normal D-dimer levels Elevated D-dimer levels* Statistical significance
Total patients (N) 93 55
Gender (N)
Male 58 27 NS
Female 62 28 NS
Age (mean) (yrs) 45 50 p = 0.0403
Number of patients with
more than one stroke or 
TIA (%) 42 (45) 27 (49) NS
Number of patients who 
presented with TIAs (%) 26 (60) 17 (40) NS
Population group (%)
Black 29 (60) 19 (40) p = 0.123 
Indian 9 (100) 0 (0)
Coloured 5 (56) 4 (44) p = 0.123 
White 50 (61) 32 (39) p = 0.123 
Mean time to assessment 
(standard deviation) (yrs) 2 (3.2) 1.7  (3) p = 0.0466
Time to assessment (range) 
(yrs) 0.01 - 22.8 0.03 - 14.4 
*Elevated D-dimers defined as more than 250 ng/ml (Heaton et al.12)
NS = non-significant.
Fig. 1. Mean ESR versus D-dimer levels in all patients (N = 148).
Patients with normal D-dimers (N = 93) had a significantly lower mean
ESR of 8 mm/h (SD 8) than those with elevated D-dimers (N = 55), mean
ESR 16 mm/h (SD 21), p = 0.0094 (*** = p < 0.01).
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there was a weak correlation between the elevated ESR and
increased fibrinogen levels (r = 0.48). There was no statistically
significant difference in normal and elevated ESR levels versus
time interval since cerebrovascular event for young (p = 0.3) or
older patients (p = 0.7).
Only 5 patients had an elevated WCC. We found no
correlation between the mean ESR and mean WCC for all
patients or within the groups with normal and elevated D-
dimers.  In those patients with elevated D-dimers, 6 (12%) had
a normal WCC with a raised ESR, whereas 2 of the 3 patients
with a raised WCC had a raised ESR (p = 0.052).
Only 3 patients had identifiable infection at the time of their
cerebrovascular event (bronchopneumonia, meningoence-
phalitis, pelvic inflammatory disease and tonsillitis).The patient
with pelvic inflammatory disease and tonsillitis was the only
one to demonstrate an elevated ESR (77 mm/hour) in
association with elevated D-dimers. None of the 43 patients
tested was found to be HIV-positive. 
Twelve  patients exhibited clinical features of an
autoimmune disease or vasculitis, including rheumatoid
arthritis, Takayasu’s disease, Raynaud’s phenomenon, and
systemic lupus eythematosus (SLE). Only 3 demonstrated an
elevated ESR at the time of testing and 2 of those 3 had an
associated elevation in D-dimer levels. Only 5 patients with an
elevated ESR had evidence of autoimmune disease or infection. 
Fig. 2. Mean ESR in younger and older patients (> 45 years) with: (a) normal and (b) elevated D-dimer levels.
(a) Of the 93 patients with normal D-dimers, 49 were 45 years or younger, mean ESR 8 mm/h (SD 8.4), and 44 were older than 45 years, mean ESR 
8 mm/h (SD 7), p = 0.75 (non-significant).
(b) However, significant difference was observed in 21 of the 55 patients 45 years and younger with elevated D-dimers, mean ESR 27 mm/h (SD 30),
compared with the 34 patients who were older, mean ESR 9 mm/h (SD 6), p = 0.0493 (* = p < 0.05).
Fig. 3. Mean ESR versus D-dimer levels in: (a) females and (b) males respectively.
(a) Ninety-two females were assessed: 62 had normal D-dimers, mean ESR 9 mm/h (SD 9) and 28 had elevated D-dimers, mean ESR 21 mm/h (SD 27), 
p = 0.0407 (* p < 0.05).
(b) Thirty-one of 58 males had normal D-dimers, mean ESR 6 mm/h (SD 6) and 28 had elevated D-dimers, mean ESR 11 mm/h (SD 11), p = 0.0235 
(** = p < 0.03).
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Discussion
Our study found that patients who had had an ischaemic
stroke or TIA, and who had elevated D-dimer levels,
suggesting ongoing thrombosis and fibrinolysis, were more
likely to have laboratory evidence of inflammation as
manifested by an elevated ESR than those with normal D-
dimer levels. An elevated ESR in the presence of raised D-
dimers was most common in young and black patients, and
was seldom associated with obvious infection or autoimmune
disease. 
Infection may precipitate stroke in many ways. Ischaemic
stroke has long been known to complicate chronic meningeal
infections that cause inflammation and secondary thrombosis.18
Some viruses can cause peri-arterial inflammation, particularly
in people with HIV.19 HIV itself may precipitate stroke via a
vasculopathy or indirectly secondary to opportunistic
infections or coagulopathy.19,20 Even in the absence of HIV
infection, recent or current systemic infection may increase
stroke risk by inducing inflammation and creating a
prothrombotic state.2,21 There has also been much  recent
interest in the role of infectious agents such as Chlamydia
pneumoniae and Helicobacter pylori in the pathogenesis of
atherosclerosis.22-24
We found no correlation between the WCC and ESR. Only 3
of our patients had evidence of infection at the time of stroke
and of these only 1 had a raised ESR together with elevated D-
dimers. None of our patients who consented for testing were
found to be HIV-positive. This is probably influenced by when
the study took place (early 1990s) and selection bias, as patients
were predominantly referred from a specialist neurovascular
clinic. We may have underestimated the number of people with
an elevated WCC at the time of stroke or TIA, as many patients
were assessed several months after their cerebrovascular event.
Despite this, leucocytosis does not appear to be an important
cause of  ongoing thrombosis and fibrinolysis in our study. 
The elevated ESR levels in our patients with raised D-dimer
levels, in the absence of an elevated WCC or clinical evidence
of infection, is probably the result of ongoing thrombosis and
fibrinolysis or occult inflammation. Although 12 of our patients
had autoimmune disease or vasculitis, only 3 had an elevated
ESR, 2 in the presence of raised D-dimers. Normal ESR values
increase marginally with age.9 Interestingly in our study, in
patients with elevated D-dimers the ESR was higher in
younger patients than older patients. Race is also thought to
affect the ESR, and in black subjects normal ESR values are at
least 2 - 13 mm/hour higher than in whites, even after
correcting for age, haemoglobin concentration and chronic
disease.25,26 However, black patients were if anything over-
represented in the group with normal D-dimer levels. 
Atherosclerosis is increasingly being accepted as an
inflammatory disease,2 and is associated with elevated
inflammatory markers such as CRP and fibrinogen.3 Acute and
chronic infection and inflammation may induce a
prothrombotic state with altered coagulation/fibrinolysis and
platelet activation2 that leads to stroke or myocardial infarction.
While atherosclerosis may account for inflammation in some of
our patients, it is unlikely that this is an important cause. Our
patients with elevated ESR and D-dimer levels were mainly
young or black, and neither of these groups is likely to have
severe atherosclerotic disease. 
The question remains regarding the significance of an
Fig. 4. Mean ESR in black and white patients with: (a) normal and (b) elevated D-dimer levels.
(a) There was a statistically significant difference, p = 0.0217 (** = p < 0.03) observed between mean ESR levels in the 50 white patients, mean ESR 6
mm/h (SD 5) compared with the 29 black patients with normal D-dimers, mean ESR 10 mm/h (SD 9). 
(b) An even more significant difference was observed when comparing mean ESR levels in the 32 white patients with elevated D-dimers, ESR 10 mm/h
(SD 9) versus the 19 black patients, ESR 27 mm/h (SD 32), p = 0.00803 (*** = p < 0.01).
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elevated ESR in the absence of an identifiable cause. In 1 000
asymptomatic men aged 18 - 33 years, a persistently elevated
ESR increased the likelihood of disease in general from 3.8% to
22.7% and of myocardial infarction from 0.7% to 9% over 15
years. In some of these men the abnormal ESR preceded the
clinical manifestations by 2 - 10 years.27 Although previous
studies have indicated that an elevated ESR is a poor
prognostic marker for those at risk of cerebrovascular disease,28
and inflammation  is increasingly thought to be a risk factor for
stroke,2,3 few if any have explored the use of the ESR as a
marker of an ongoing procoagulant state. The correlation of an
elevated ESR and blood fibrinogen level in our patients with
elevated D-dimers is not surprising. Fibrinogen, the most
abundant acute-phase reactant, has the greatest effect on the
elevation of the ESR when compared with other acute-phase
reactants.9 Our findings therefore suggest that the ESR, a
readily available and inexpensive bedside test, may highlight
patients with ongoing thrombosis/fibrinolysis who are at
increased risk of further vascular events. 
However, our study has important limitations. The patients
assessed were from a potentially biased population that was
neither randomly selected nor based on consecutive
admissions or referrals. Most patients were referred from a
specialist neurovascular clinic and criteria for selection were
not determined at the start of the study. Thus patients might
have been more likely to be included, for example, if they did
not have a clear cause for their stroke or if they were HIV-
negative. The positive findings of the study are based on small
numbers.
Although there were no major differences between those
individuals with elevated and normal D-dimers (Table I), those
with elevated D-dimers were more likely to have been assessed
slightly earlier following their stroke. As time since the
cerebrovascular event affects levels of inflammatory and
coagulation markers this may have influenced our results. 
Ideally, future research should include careful unbiased
patient selection and clinical and laboratory assessment both at
the time of stroke/TIA and several months later. HIV-positive
and negative patients should be clearly identified and
differences investigated. Measurement of CRP and ESR would
enable comparison between these two modalities. Finally, long-
term follow-up of all patients to determine the prognostic
significance of an elevated ESR with and without raised D-
dimers would be useful. 
In conclusion, infection and inflammation are increasingly
being recognised as risk factors for ischaemic stroke. Their role
in the pathogenesis of cerebrovascular disease is complex.
Inflammation may activate coagulation with or without the
presence of atherosclerosis. Our study raises the possibility that
a persistently elevated ESR in someone who has had a stroke
or TIA may imply ongoing thrombosis/fibrinolysis. The ready
availability and ease of performing this inexpensive bedside
test makes further research to clarify its role in our South
African setting compelling.
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